Can the peptide receptor radionuclide therapy [177Lu]Lu-DOTA-TATE provide a net benefit for NET patients? :: Library Catalog

library@stipram.ac.id (0274) 485 650

Pengumuman Berita Terbaru PMB

Can the peptide receptor radionuclide therapy [177Lu]Lu-DOTA-TATE provide a net benefit for NET patients?

oleh: Martyn E. Caplin

Format:	Article
Diterbitkan:	Elsevier 2021-11-01

Deskripsi

Subjek

Cost; Cost-effectiveness; Neuroendocrine tumours; [177Lu]Lu-DOTA-TATE; Quality of life; PFS